PharmaCielo Ltd. (TSXV:PCLO) signed a letter of intent to acquire Siam Ventures Corporation for CAD 3 million on April 10, 2024. The Purchase Price shall be payable on closing of the Proposed Acquisition by way of the issuance of 13,636,363 PharmaCielo Shares to the shareholders of Siam Ventures on a pro rata basis, representing the equivalent of CAD 3 million. The number of Consideration Shares to be issued have been determined based on a price of $0.22 per Consideration Share.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.155 CAD | -3.13% |
|
-.--% | -13.89% |
1st Jan change | Capi. | |
---|---|---|
-13.89% | 1.93Cr | |
+27.19% | 555.72Cr | |
-33.59% | 352.1Cr | |
-2.97% | 301.29Cr | |
-24.21% | 265.11Cr | |
-10.11% | 230.42Cr | |
+43.66% | 190.69Cr | |
+46.15% | 150.33Cr | |
-13.92% | 141.2Cr | |
+41.90% | 137.29Cr |
- Stock Market
- Equities
- PCLO Stock
- News PharmaCielo Ltd.
- PharmaCielo Ltd. signed a letter of intent to acquire Siam Ventures Corporation for CAD 3 million.